iRhythm Technologies Inc
NASDAQ:IRTC

Watchlist Manager
iRhythm Technologies Inc Logo
iRhythm Technologies Inc
NASDAQ:IRTC
Watchlist
Price: 89.37 USD 0.8% Market Closed
Market Cap: 2.8B USD
Have any thoughts about
iRhythm Technologies Inc?
Write Note

Gross Margin
iRhythm Technologies Inc

67.8%
Current
68%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.8%
=
Gross Profit
379.9m
/
Revenue
560m

Gross Margin Across Competitors

Country US
Market Cap 2.8B USD
Gross Margin
68%
Country US
Market Cap 199B USD
Gross Margin
56%
Country US
Market Cap 191.3B USD
Gross Margin
67%
Country US
Market Cap 141.3B USD
Gross Margin
64%
Country US
Market Cap 134.2B USD
Gross Margin
69%
Country IE
Market Cap 104.6B USD
Gross Margin
65%
Country US
Market Cap 65.6B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.5B USD
Gross Margin
79%
Country CN
Market Cap 310B CNY
Gross Margin
64%
Country US
Market Cap 36.3B USD
Gross Margin
41%
No Stocks Found

iRhythm Technologies Inc
Glance View

Market Cap
2.8B USD
Industry
Health Care

In the bustling realm of healthcare technology, where innovation meets necessity, iRhythm Technologies Inc. stands as a pivotal player, translating sophisticated algorithms into tangible, life-saving insights. Founded with the mission to redefine how cardiac care is delivered, iRhythm has pioneered its niche through the Zio platform—a sophisticated, wearable patch that monitors heart rhythms with precision. The Zio's elegant design belies its robust function, offering patients the comfort of continuous monitoring while living their daily lives. It gleans crucial data that is then transmitted to iRhythm's cloud-based platform, where advanced data analytics work tirelessly to think like a seasoned cardiologist, initially parsing through millions of heartbeats to identity potential abnormalities. As healthcare systems worldwide grapple with increasing demands and complexities, iRhythm's business model resonates well with the need for efficiency and effectiveness. The company generates revenue primarily through its patient-centric monitoring services, catering to healthcare providers who seek reliable diagnostic solutions. By billing insurers and healthcare institutions for the analytic results derived from the Zio patch, iRhythm seamlessly integrates into the cardiac care continuum. The blend of cutting-edge technology and strategic partnerships with healthcare providers not only fuels iRhythm's growth but also underscores a broader shift towards personalized and preventive medicine in cardiac care, demonstrating how strategic foresight can align with technical innovation to meet pressing healthcare challenges.

IRTC Intrinsic Value
55.54 USD
Overvaluation 38%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.8%
=
Gross Profit
379.9m
/
Revenue
560m
What is the Gross Margin of iRhythm Technologies Inc?

Based on iRhythm Technologies Inc's most recent financial statements, the company has Gross Margin of 67.8%.